Kynam Capital Management Increases Stake in Burning Rock Biotech Ltd to 13.97%

Kynam Capital Management, LP, along with Kynam Capital Management GP, LLC and Yue Tang, filed a Schedule 13G/A on May 15, 2026, disclosing a significant ownership stake in Burning Rock Biotech Ltd (BNR). As of the event date on March 31, 2026, the reporting persons collectively hold 1,227,555 Class A Ordinary Shares, represented by American Depository Shares (ADSs). This position constitutes a 13.97% ownership interest in the company. The filing indicates shared voting and dispositive power over all reported shares among the three reporting entities. This amendment reflects an increase from previously reported holdings, establishing Kynam Capital Management as a substantial institutional investor in the China-based biotechnology firm. The securities were acquired in the ordinary course of business, and the filing includes a certification that the acquisition was not intended to influence or change the control of the issuer. The principal business office for the reporting persons is located in Princeton, New Jersey.